Noltes, Milou E.
van Dam, Gooitzen M.
Nagengast, Wouter B.
van der Zaag, Pieter J.
Slart, Riemer H. J. A.
Szymanski, Wiktor
Kruijff, Schelto
Dierckx, Rudi A. J. O.
Article History
First Online: 31 August 2021
Change Date: 26 September 2021
Change Type: Update
Change Details: The article was modified to correct some texts that were captured without spaces between them.
Declarations
:
: Institutional review board approval was not required because the paper is an editorial.
: Not applicable.
: GMvD is CEO, founder and shareholder of TRACER Europe BV / AxelaRx. The other authors declare no competing interests.
Free to read: This content has been made available to all.